• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    99 Biggest Movers From Yesterday

    5/12/22 4:29:56 AM ET
    $AFI
    $ANPC
    $APEI
    $ATLC
    Building Products
    Capital Goods
    Medical Specialities
    Health Care
    Get the next $AFI alert in real time by email

    Gainers

    • Armstrong Flooring, Inc. (NYSE:AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.
    • Regulus Therapeutics Inc. (NASDAQ:RGLS) surged 54.8% to close at $0.2660 after the company announced the FDA has accepted its Investigational New Drug Application for RGLS8429 for the treatment of Autosomal Dominant Polycystic Kidney Disease.
    • Sunlands Technology Group (NYSE:STG) rose 34.3% to settle at $3.29.
    • Trecora Resources (NYSE:TREC) shares gained 26% to close at $9.51 on Wednesday as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247 million.
    • Golden Matrix Group, Inc. (NASDAQ:GMGI) rose 23.9% to settle at $4.25.
    • Charge Enterprises, Inc. (NASDAQ:CRGE) gained 22.1% to close at $3.65.
    • Inspired Entertainment, Inc. (NASDAQ:INSE) jumped 21.3% to close at $10.65 after the company reported better-than-expected Q1 EPS and sales results and approved a $25 million.
    • Regis Corporation (NYSE:RGS) gained 20.1% to close at $0.8901. Regis recently reported worse-than-expected Q3 EPS and sales results.
    • H&R Block, Inc. (NYSE:HRB) gained 19.5% to close at $28.41 as the company posted upbeat Q3 results and raised FY22 sales guidance.
    • Blue Water Vaccines, Inc. (NASDAQ:BWV) jumped 18.5% to close at $6.01. Blue Water Vaccines reported expanded license deal with St. Jude Children's Hospital for novel bacterial vaccine platform.
    • Alpha Teknova, Inc. (NASDAQ:TKNO) gained 17% to settle at $12.16. Alpha Teknova posted Q1 sales of $11.10 million.
    • AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) jumped 16.4% to close at $0.30. AnPac Bio regained compliance with market-value-of-publicly held shares requirement upon transfer to the Nasdaq Capital Market.
    • BioSig Technologies, Inc. (NASDAQ:BSGM) gained 16.3% to settle at $1.00.
    • TORM plc (NASDAQ:TRMD) surged 16.2% to close at $11.35.
    • Embark Technology, Inc. (NASDAQ:EMBK) gained 16.1% to close at $1.66. Embark Technology posted a Q1 loss of $0.04 per share.
    • GlucoTrack, Inc. (NASDAQ:GCTK) rose 15.9% to close at $2.85.
    • Celsius Holdings, Inc. (NASDAQ:CELH) jumped 14.8% to close at $47.42 after the company reported better-than-expected Q1 sales results.
    • Grocery Outlet Holding Corp. (NASDAQ:GO) surged 14.7% to settle at $35.65 after the company reported better-than-expected Q1 EPS and sales results.
    • Sylvamo Corporation (NYSE:SLVM) gained 14.7% to close at $44.68 following Q1 results.
    • Renovacor, Inc. (NYSE:RCOR) rose 13.3% to close at $2.72.
    • Borr Drilling Limited (NYSE:BORR) jumped 10.6% to settle at $4.38.
    • Callaway Golf Company (NYSE:ELY) surged 10.2% to settle at $19.80 after the company reported better-than-expected Q1 EPS and sales results and issued FY22 revenue guidance above analyst estimates.
    • Switch, Inc. (NYSE:SWCH) rose 9.1% to close at $33.54 after the company announced it will be taken private by DigitalBridge Investment Management and IFM in an $11 billion transaction.
    • Desktop Metal, Inc. (NYSE:DM) rose 8.3% to close at $1.44. Desktop Metal priced its $100 million convertible senior notes offering.
    • Electronic Arts Inc. (NASDAQ:EA) gained 8% to close at $120.49 after the company reported Q4 financial results and issued FY23 guidance.
    • Endeavour Silver Corp. (NYSE:EXK) surged 7.7% to close at $3.34 following upbeat quarterly results.
    • INNOVATE Corp. (NYSE:VATE) gained 7.4% to close at $2.48. Innovate recently posted Q1 loss of $0.18 per share.
    • Exicure, Inc. (NASDAQ:XCUR) gained 7.2% to close at $0.1140 after the company reported a $5 million raise in private placement transaction priced at market premium.
    • Ferroglobe PLC (NASDAQ:GSM) gained 6.6% to close at $6.78 after the company reported better-than-expected Q1 EPS results.
    • Organogenesis Holdings Inc. (NASDAQ:ORGO) gained 6.3% to close at $5.88 following Q1 results.
    • Electra Battery Materials Corporation (NASDAQ:ELBM) shares rose 5.7% to close at $3.93 after the company issued an an Update on its Cobalt-Copper Mineral Project in Idaho.
    • Veru Inc. (NASDAQ:VERU) rose 4.8% to $8.16. In a Pre-EUA meeting, FDA said Veru should submit a request for FDA emergency use authorization for sabizabulin in hospitalized COVID-19 patients.
    •  

    Losers

    • View, Inc. (NASDAQ:VIEW) shares tumbled 62% to close at $0.5163 on Wednesday after the company in a 10-Q filing said it does not currently have adequate financial resources to fund its forecasted operating costs and will look to raise capital.
    • IT Tech Packaging, Inc. (NYSE:ITP) fell 43.7% to close at $0.1802 after the company reported Q1 sales results were lower year over year.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) fell 42.9% to close at $3.20. Chicken Soup For The Soul Entertainment Inc (NASDAQ:CSSE) agreed to acquire entertainment company Redbox Entertainment. The acquisition is expected tocreate an independent, integrated direct-to-consumer media platform delivering premium entertainment.
    • Unity Software Inc. (NYSE:U) fell 37.1% to settle at $30.30 after the company reported worse-than-expected Q1 sales results and issued sales guidance below analyst estimates.
    • SQL Technologies Corp. (NASDAQ:SKYX) dropped 37% to close at $3.73.
    • Digital Media Solutions, Inc. (NYSE:DMS) tumbled 35.4% to settle at $1.79 following Q1 results.
    • Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) fell 34.6% to settle at $12.00. Opiant Pharmaceuticals posted a Q1 loss of $2.43 per share.
    • Kornit Digital Ltd. (NASDAQ:KRNT) shares fell 33.3% to close at $37.63 after the company reported downbeat Q1 sales.
    • Verb Technology Company, Inc. (NASDAQ:VERB) dropped 32.4% to settle at $0.3416.
    • Aspira Women's Health Inc. (NASDAQ:AWH) dropped 32.4% to settle at $0.4003 following weak quarterly sales.
    • Trevena, Inc. (NASDAQ:TRVN) declined 31.8% to close at $0.1958 after reporting a wider quarterly loss.
    • LM Funding America, Inc. (NASDAQ:LMFA) dropped 30.1% to settle at $1.14.
    • Vaxxinity, Inc. (NASDAQ:VAXX) fell 29.9% to close at $3.98. Vaxxinity recently posted Q1 loss of $0.15 per share.
    • OTR Acquisition Corp. (NASDAQ:OTRA) shares dropped 29.9% to settle at $9.99.
    • iTeos Therapeutics, Inc. (NASDAQ:ITOS) declined 29.8% to close at $18.00.
    • Smart for Life, Inc. (NASDAQ:SMFL) dropped 29.7% to close at $0.6184.
    • Arcus Biosciences, Inc. (NYSE:RCUS) dipped 28.2% to settle at $17.23. Arcus Biosciences recently posted a Q1 loss of $0.96 per share.
    • Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) fell 27.7% to close at $0.4884. Infinity Pharmaceuticals recently posted a Q1 loss of $0.14 per share.
    • Vaccitech plc (NASDAQ:VACC) fell 27.6% to close at $3.26 following Q1 earnings.
    • Inovio Pharmaceuticals, Inc. (NASDAQ:INO) fell 27.3% to close at $1.81 after the company reported worse-than-expected Q1 EPS results.
    • Oncternal Therapeutics, Inc. (NASDAQ:ONCT) dipped 27% to settle at $0.7301.
    • Avinger, Inc. (NASDAQ:AVGR) fell 26.9% to close at $1.70 following weak quarterly sales.
    • Cyngn Inc. (NASDAQ:CYN) declined 26.8% to close at $3.69. Cyngn posted a Q1 loss of $0.14 per share.
    • Vigil Neuroscience, Inc. (NASDAQ:VIGL) dropped 26.7% to settle at $2.25.
    • Coinbase Global, Inc. (NASDAQ:COIN) fell 26.4% to close at $53.72 after the company reported worse-than-expected Q1 sales results.
    • Fiverr International Ltd. (NYSE:FVRR) fell 25.6% to close at $30.39 after the company reported Q1 earnings results.
    • MicroStrategy Incorporated (NASDAQ:MSTR) dipped 25.4% to settle at $168.20 in sympathy with the price of bitcoin and ethereum.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) dropped 25.3% to settle at $5.19.
    • Conformis, Inc. (NASDAQ:CFMS) dropped 25% to settle at $0.3027. Conformis recently posted a Q1 loss of $0.09 per share.
    • TherapeuticsMD, Inc. (NASDAQ:TXMD) declined 24.8% to close at $3.46.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) dropped 23.8% to settle at $0.5502. Wells Fargo recently upgraded the stock from Equal-Weight to Overweight and announced a $3 price target.
    • BRP Group, Inc. (NASDAQ:BRP) fell 23.6% to close at $17.81 after reporting downbeat quarterly earnings.
    • 908 Devices Inc. (NASDAQ:MASS) dropped 23.6% to close at $13.54. 908 Devices recently posted a Q1 loss of $0.30 per share.
    • HyreCar Inc. (NASDAQ:HYRE) declined 23.5% to settle at $1.01.
    • WiSA Technologies, Inc. (NASDAQ:WISA) dropped 23.4% to close at $0.72. WiSA Technologies reported a first-quarter FY22 revenue decline of 50% year-on-year to $0.6 million, missing the consensus of $1.38 million.
    • Mereo BioPharma Group plc (NASDAQ:MREO) declined 23.1% to close at $0.33. Mereo BioPharma recently announced topline efficacy and safety results from ASTRAEUS Phase 2 study of alvelestat (MPH-966) in severe alpha-1 antitrypsin deficiency-(AATD) associated emphysema.
    • MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) dropped 22.8% to close at $2.32.
    • Canoo Inc. (NASDAQ:GOEV) fell 22.7% to close at $2.79 following Q1 loss.
    • GrowGeneration Corp. (NASDAQ:GRWG) fell 22.7% to settle at $3.84 after the company reported worse-than-expected Q1 EPS and sales results and cut FY22 sales guidance to below analyst estimates.
    • BTRS Holdings Inc. (NASDAQ:BTRS) declined 22.7% to close at $4.26 after the company reported worse-than-expected Q1 EPS results.
    • American Public Education, Inc. (NASDAQ:APEI) dipped 22.6% to close at $13.75 following Q1 results.
    • HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE) fell 22.6% to settle at $0.9217. HIVE Blockchain, late Tuesday, proposed 5 to 1 share consolidation.
    • Avaya Holdings Corp. (NASDAQ:AVYA) declined 22.4% to settle at $5.84. JP Morgan downgraded Avaya from Neutral to Underweight and lowered the price target from $16 to $7.
    • ImmunityBio, Inc. (NASDAQ:IBRX) fell 22.3% to close at $2.68.
    • Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) declined 22.2% to close at $1.79.
    • UserTesting, Inc. (NYSE:USER) fell 22.1% to settle at $4.36.
    • The RealReal, Inc. (NASDAQ:REAL) fell 22% to close at $3.44 following Q1 results.
    • Calithera Biosciences, Inc. (NASDAQ:CALA) declined 21.8% to close at $0.16 after reporting 1 results.
    • Eastman Kodak Company (NYSE:KODK) dipped 21.7% to settle at $3.86 following Q1 results.
    • FingerMotion, Inc. (NASDAQ:FNGR) declined 21.5% to close at $1.53.
    • Redwire Corporation (NYSE:RDW) fell 21.2% to close at $3.93.
    • Epizyme, Inc. (NASDAQ:EPZM) dropped 21.2% to settle at $0.4677 following weak quarterly results.
    • Berkeley Lights, Inc. (NASDAQ:BLI) fell 21.2% to close at $3.7650. Berkeley Lights recently posted a Q1 loss of $0.32 per share.
    • Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) declined 21% to close at $0.9322.
    • Atlanticus Holdings Corporation (NASDAQ:ATLC) fell 20.8% to settle at $31.98 following Q1 results.
    • GH Research PLC (NASDAQ:GHRS) fell 20.7% to close at $9.64.
    • Novavax, Inc. (NASDAQ:NVAX) dipped 20.3% to close at $42.92 after the company reported worse-than-expected Q1 EPS and sales results.
    • Super League Gaming, Inc. (NASDAQ:SLGG) fell 20.3% to settle at $1.02.
    • ThredUp Inc. (NASDAQ:TDUP) fell 19.5% to close at $4.20.
    • Senseonics Holdings, Inc. (NYSE:SENS) fell 16.1% to settle at $1.04 after reporting Q1 results.
    • BeiGene, Ltd. (NASDAQ:BGNE) fell 15.7% to close at $121.11. BeiGene recently posted a Q1 loss of $4.24 per share.
    • Evaxion Biotech A/S (NASDAQ:EVAX) shares fell 15.1% to close at $1.91.
    • Ichor Holdings, Ltd. (NASDAQ:ICHR) declined 13.7% to close at $25.16 after the company reported worse-than-expected Q1 EPS and sales results.
    • Evotec SE (NASDAQ:EVO) fell 13.2% to close at $10.89. Evotec recently announced it extended and expanded its partnership with Bristol Myers Squibb in targeted protein degradation.
    • Allbirds, Inc. (NASDAQ:BIRD) shares fell 11.7% to close at $3.99 after the company Q1 earnings results.
    • Neuronetics, Inc. (NASDAQ:STIM) fell 11.4% to settle at $2.09. Neuronetics said it has filed Federal suit against Brainsway for 'misleading psychiatrists, patients.'
    • The Wendy's Company (NASDAQ:WEN) dropped 11.2% to close at $16.07 as the company reported first-quarter FY22 sales growth of 6.2% year-on-year to $488.6 million, missing the consensus of $497.1 million.
    Get the next $AFI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFI
    $ANPC
    $APEI
    $ATLC

    CompanyDatePrice TargetRatingAnalyst
    Celsius Holdings Inc.
    $CELH
    2/27/2026$65.00Underperform → Buy
    BofA Securities
    Grocery Outlet Holding Corp.
    $GO
    2/25/2026$10.50Overweight → Equal Weight
    Wells Fargo
    Evaxion A/S
    $EVAX
    2/19/2026$10.00Buy
    Maxim Group
    Fiverr International Ltd.
    $FVRR
    2/19/2026$15.00Overweight → Neutral
    Analyst
    Fiverr International Ltd.
    $FVRR
    2/19/2026$14.00Buy → Neutral
    Roth Capital
    Fiverr International Ltd.
    $FVRR
    2/18/2026Buy → Hold
    Needham
    Coinbase Global Inc.
    $COIN
    2/12/2026$120.00Buy → Neutral
    Monness Crespi & Hardt
    Arcus Biosciences Inc.
    $RCUS
    2/12/2026$23.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $AFI
    $ANPC
    $APEI
    $ATLC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for TAZVERIK issued to EPIZYME INC

    Submission status for EPIZYME INC's drug TAZVERIK (SUPPL-5) with active ingredient TAZEMETOSTAT HYDROBROMIDE has changed to 'Approval' on 08/13/2024. Application Category: NDA, Application Number: 211723, Application Classification: Labeling

    8/14/24 4:43:30 AM ET
    $EPZM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFI
    $ANPC
    $APEI
    $ATLC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Expanse Studios Announces Multi-Market European Partnership with ESA Gaming

    LAS VEGAS, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Expanse Studios, a leading B2B iGaming content provider and subsidiary of Golden Matrix Group Inc. (NASDAQ:GMGI), today announced a strategic partnership with ESA Gaming, an established European aggregation platform specializing in mobile-first gaming content and multi-jurisdictional distribution. The partnership marks a significant milestone in Expanse Studios' European expansion and strengthens Golden Matrix Group's broader B2B distribution objectives. The agreement positions Expanse's proprietary content across ESA Gaming's operator network. ESA Gaming operates a comprehensive Game Aggregator System (GAS) serving over 90 content providers a

    2/27/26 12:22:06 PM ET
    $GMGI
    Computer Software: Prepackaged Software
    Technology

    Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments

    Issued on behalf of Helus PharmaVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity-Insider.com News Commentary -- Psychedelic compounds are edging closer to regulatory approval as pivotal trials in treatment-resistant depression and anxiety advance through late-stage development[1]. The sector is shedding its countercultural reputation as biotech firms reposition serotonergic and psychedelic-derived therapies as mainstream pharmaceutical candidates[2]. Five companies are building the clinical programs to get there: Helus Pharma (NASDAQ:HELP), AtaiBeckley (NASDAQ:ATAI), Definium Therapeutics (NASDAQ:DFTX), GH Research (NASDAQ:GHRS), and LB Pharmaceuticals (NASDAQ:LBRX).

    2/27/26 11:44:00 AM ET
    $ATAI
    $DFTX
    $GHRS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medicinal Chemicals and Botanical Products

    Industrial Silver Demand Is Rewriting the Supply Equation, Explorers Are Racing to Fill the Gap

    Issued on behalf of Americore Resources Corp.Equity-Insider.com News CommentaryVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Industrial silver fabrication accounts for nearly 60% of total global demand, with industrial use reaching 680 million ounces in 2024 as solar photovoltaic installations, electric vehicle production, and AI server manufacturing continue to absorb physical supply[1]. Global EV production is forecast to reach 14 to 15 million units in 2026, adding an estimated 70 to 75 million ounces of silver demand from automotive applications alone[1]. These consumption trends are attracting attention to Americore Resources (TSXV:AMCO) (OTCQB:AMCOF), Endeavour Silver (NYSE:EXK), Aya Gold & Si

    2/27/26 11:43:00 AM ET
    $EXK
    Precious Metals
    Basic Materials

    $AFI
    $ANPC
    $APEI
    $ATLC
    SEC Filings

    View All

    SEC Form 10-K filed by Redwire Corporation

    10-K - Redwire Corp (0001819810) (Filer)

    2/27/26 5:15:43 PM ET
    $RDW
    Military/Government/Technical
    Industrials

    Eastman Kodak Company Common New filed SEC Form 8-K: Leadership Update

    8-K - EASTMAN KODAK CO (0000031235) (Filer)

    2/27/26 5:00:27 PM ET
    $KODK
    Industrial Machinery/Components
    Consumer Discretionary

    SEC Form 6-K filed by Evaxion A/S

    6-K - Evaxion A/S (0001828253) (Filer)

    2/27/26 4:45:16 PM ET
    $EVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AFI
    $ANPC
    $APEI
    $ATLC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief Financial Officer Yahes Jarrod sold $220,382 worth of shares (12,196 units at $18.07), decreasing direct ownership by 2% to 533,933 units (SEC Form 4)

    4 - Unity Software Inc. (0001810806) (Issuer)

    2/27/26 5:29:17 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    Chief Accounting Officer Barrysmith Mark sold $191,144 worth of shares (10,578 units at $18.07), decreasing direct ownership by 3% to 383,901 units (SEC Form 4)

    4 - Unity Software Inc. (0001810806) (Issuer)

    2/27/26 5:24:37 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    SVP, Chief Operating Officer Blum Alexander sold $231,333 worth of shares (12,705 units at $18.21), decreasing direct ownership by 2% to 548,425 units (SEC Form 4)

    4 - Unity Software Inc. (0001810806) (Issuer)

    2/27/26 5:20:17 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    $AFI
    $ANPC
    $APEI
    $ATLC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Thompson Tommy G bought $14,031 worth of shares (8,400 units at $1.67), increasing direct ownership by 57% to 23,179 units (SEC Form 4)

    4 - TherapeuticsMD, Inc. (0000025743) (Issuer)

    12/29/25 4:23:31 PM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Leong Yew Poh decreased direct ownership by 6% to 160,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/29/25 6:26:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    Director Leong Yew Poh decreased direct ownership by 6% to 170,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/8/25 7:08:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    $AFI
    $ANPC
    $APEI
    $ATLC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Celsius upgraded by BofA Securities with a new price target

    BofA Securities upgraded Celsius from Underperform to Buy and set a new price target of $65.00

    2/27/26 8:20:43 AM ET
    $CELH
    Beverages (Production/Distribution)
    Consumer Staples

    Grocery Outlet downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Grocery Outlet from Overweight to Equal Weight and set a new price target of $10.50

    2/25/26 7:39:36 AM ET
    $GO
    Food Chains
    Consumer Staples

    Maxim Group initiated coverage on Evaxion Biotech with a new price target

    Maxim Group initiated coverage of Evaxion Biotech with a rating of Buy and set a new price target of $10.00

    2/19/26 8:24:06 AM ET
    $EVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AFI
    $ANPC
    $APEI
    $ATLC
    Leadership Updates

    Live Leadership Updates

    View All

    Cyngn Adds Former Lyft Exec, Ran Makavy, to Board

    Mr. Makavy led growth at Lyft and later ran its core platform through the 2019 IPO. He also founded Snaptu, which was acquired by Facebook in 2011.MOUNTAIN VIEW, Calif., Feb. 25, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced the appointment of Ran Makavy to its Board of Directors. He brings senior growth and platform leadership experience from Lyft and Facebook, where he helped scale large technology businesses through high-growth phases. At Lyft, Makavy built the growth team which was responsible for getting more drivers and riders to use Lyft and getting them to use

    2/25/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    Diality Appoints Peter Donato as Chief Financial Officer

    Life sciences veteran brings private and public sector expertise to company in midst of growth trajectory Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-flx Hemodialysis System while preparing for a limited market release in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224064413/en/Diality CFO Peter Donato. Donato joins Diality with nearly 35 years of financial leadershi

    2/24/26 7:05:00 AM ET
    $MYGN
    $STIM
    $TFX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Medical/Dental Instruments
    Pharmaceuticals and Biotechnology

    LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary

    BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (NASDAQ:LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has appointed Sidney Braun as Chief Executive Officer of the Company's Liora Technologies Europe Ltd. subsidiary ("Liora"). A veteran of the healthcare industry, Braun brings to Liora more than two decades of operational and strategic advisory experience at companies in North America, Europe and Israel. He was instrumental in the creation of Liora and facilitated LIXTE's acquisition of Liora's assets in November 2025 from Orbit Capital, Inc. Over his

    2/18/26 8:00:00 AM ET
    $LIXT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFI
    $ANPC
    $APEI
    $ATLC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Arcus Biosciences Inc.

    SC 13D/A - Arcus Biosciences, Inc. (0001724521) (Subject)

    12/17/24 9:52:58 PM ET
    $RCUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13D filed by Neuronetics Inc.

    SC 13D - Neuronetics, Inc. (0001227636) (Subject)

    12/17/24 9:15:11 PM ET
    $STIM
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by BeiGene Ltd.

    SC 13D/A - BeiGene, Ltd. (0001651308) (Subject)

    12/10/24 9:30:34 PM ET
    $BGNE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFI
    $ANPC
    $APEI
    $ATLC
    Financials

    Live finance-specific insights

    View All

    ImmunityBio to Provide a Business Update and Review Financial Results for FY 2025 on Tuesday, March 3, 2026

    ImmunityBio, Inc. ((IBRX), today announced that it will host a live conference call at 1:30 p.m. Pacific Time on Tuesday, March 3, 2026, to provide a business update, including progress across the company's clinical trial pipeline, and to review financial results for the year ended December 31, 2025. Conference Call Details The conference call will begin at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Tuesday, March 3, 2026. Interested parties may access the conference call through our Investor Relations website, ir.immunitybio.com, under Company — Events & Presentations. Alternatively, individuals can access the call by dialing 1-844-539-3703 or 1-412-652-1273 (internationally).

    2/27/26 7:30:00 AM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Endeavour Silver Announces Q4 2025 Financial Results; Earnings Call at 10AM PST (1PM EST) Today

    VANCOUVER, British Columbia, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. ("Endeavour" or the "Company") (NYSE:EXK, TSX:EDR) announces its financial and operating results for the three months and year ended December 31, 2025. All dollar amounts are in US dollars ($). "2025 was a transformative year for Endeavour, marked by robust production growth, record revenues and key strategic milestones that have propelled the Company forward," said Dan Dickson, Chief Executive Officer. "The successful commissioning of Terronera, the acquisition of Kolpa and the sale of Bolañitos Mine have not only enhanced the Company's asset portfolio but also positioned it for sustained growth and lon

    2/27/26 6:50:00 AM ET
    $EXK
    Precious Metals
    Basic Materials

    Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue

    CANTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacturing, and sale of products for the advanced wound care, and surgical and sports medicine markets, today reported financial results for the fourth quarter and the year ended December 31, 2025. Fourth Quarter 2025 Financial Results Summary: Net product revenue of $225.1 million for the fourth quarter of 2025, an increase of $98.4 million compared to net product revenue of $126.7 million for the fourth quarter of 2024. Net product revenue for the fourth quarter of 2025 consis

    2/26/26 4:05:00 PM ET
    $ORGO
    Biotechnology: Pharmaceutical Preparations
    Health Care